Ufr Medecine Urca
Reims, 51100, France
NCT Number: NCT07440082
Sexual health, according to the World Health Organization (WHO), is a state of overall well-being related to sexuality. In the postpartum period, sexual health is often affected by hormonal, physical, and psychological changes. Up to 83% of women report sexual difficulties within the first three months after childbirth, and these issues may persist for up to a year. Dyspareunia is one of the most common symptoms, affecting approximately 35% of postpartum women. Other difficulties include vaginal dryness, fatigue, decreased libido, and fear of pain. Breastfeeding and perineal trauma are known to influence the resumption of sexual activity.
Health professionals may lack training or confidence in addressing sexual health, often leaving women to cope with their difficulties alone, even though they express a need for information and support. In this context, it is essential to better understand the difficulties women face when resuming sexual activity after childbirth, in order to improve the detection and management of sexual health disorders.
Looking for future studies?
Notify Me18 year and older
Female
Observational
Reims, 51100, France
Objectives Primary: To describe the resumption of sexual activity within the first 3 months postpartum, including any potential difficulties encountered.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
data collection
Time frame: Day0
Proportion of participants who resumed sexual intercourse within the 3 months following childbirth
Université de Reims Champagne-Ardenne
Other
Acronym: RS-PP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06850467
Behavior, Coitus
Tunis6-TUNISIA, Tunis Governorate, Tunisia
View Trial DetailsNCT04880590
Behavior, Coitus
Barcelona, Spain
View Trial DetailsNCT05609786
Behavior, Coitus
Nairobi, Kenya
View Trial DetailsNCT05664802
Acquired Immunodeficiency Syndrome, Behavior
Flagstaff, Arizona, United States
View Trial Details